Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.2K
Endoscopic Studies I: Bronchoscopy and Thoracoscopy01:30

Endoscopic Studies I: Bronchoscopy and Thoracoscopy

288
Endoscopy is a non-surgical medical technique used to examine a person's internal organs and vessels. This lesson will focus on two types of endoscopic studies: bronchoscopy and thoracoscopy.
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
288
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

445
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
445
The Bronchial Tree01:23

The Bronchial Tree

4.0K
The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
4.0K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

232
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
232
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

793
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
793

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

American journal of respiratory and critical care medicine·2026
Same author

The importance of symptoms in bronchiectasis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Gene expression profiling of whole blood samples following marathon running in non-elite athletes.

Biology of sport·2026
Same author

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.

The Lancet. Respiratory medicine·2026
Same author

Bronchiectasis in Italy: an analysis of the EMBARC registry.

ERJ open research·2026
Same author

Increased circulating ACE2 and GAS6 are independent predictors of COVID-19 severity.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
Same journal

In Pursuit of Excellence: The Past, Present, and Future of Quality Improvement in Pneumonia.

Clinics in chest medicine·2026
See all related articles

Related Experiment Video

Updated: Oct 1, 2025

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

11.1K

Future Directions in Bronchiectasis Research.

Rosanel Amaro1, Lídia Perea2, Oriol Sibila1

  • 1Department of Pneumology, Respiratory Institute, Hospital Clínic, Barcelona, Spain.

Clinics in Chest Medicine
|March 3, 2022
PubMed
Summary
This summary is machine-generated.

Bronchiectasis treatment requires better patient stratification due to group heterogeneity. Future research will focus on biomarkers, omics technologies, and endotypes for personalized medicine approaches.

Keywords:
BiomarkersEndotypesOmicsPersonalized medicine

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

23.0K
Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
08:42

Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures

Published on: May 26, 2023

3.3K

Related Experiment Videos

Last Updated: Oct 1, 2025

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

11.1K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

23.0K
Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
08:42

Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures

Published on: May 26, 2023

3.3K

Area of Science:

  • Pulmonology and Respiratory Medicine
  • Biomarker Discovery
  • Personalized Medicine

Background:

  • Bronchiectasis treatment presents significant challenges, with recent clinical trials yielding inconclusive results.
  • High patient group heterogeneity is a primary reason for the lack of demonstrable clinical improvement in trials.
  • There is a critical need for novel biomarkers to enable precise patient stratification in bronchiectasis.

Purpose of the Study:

  • To explore future directions in biomarker discovery for bronchiectasis.
  • To discuss the role of omics technologies and endotypes in understanding disease heterogeneity.
  • To outline the pathway toward personalized medicine for bronchiectasis patients.

Main Methods:

  • Review of current challenges in bronchiectasis clinical trials.
  • Analysis of the impact of patient heterogeneity on treatment outcomes.
  • Exploration of emerging omics technologies (genomics, proteomics, etc.).
  • Discussion of endotyping strategies for patient classification.

Main Results:

  • Current treatment strategies for bronchiectasis lack efficacy due to patient heterogeneity.
  • Biomarkers are essential for stratifying patients and tailoring treatments.
  • Omics technologies offer powerful tools for identifying novel biomarkers and endotypes.
  • Personalized medicine holds promise for improving bronchiectasis management.

Conclusions:

  • Personalized medicine, driven by advanced biomarkers and endotyping, is crucial for advancing bronchiectasis treatment.
  • Future research must focus on integrating omics data to define distinct patient subgroups.
  • Developing targeted therapies based on identified endotypes will improve clinical outcomes in bronchiectasis.